Ling Zhong

机构：University of Electronic Science and Technology of China · ORCID：0000-0002-1549-0423

发表论文 59 篇 · 总被引 1266 次 · h-index 19

代表论文

• Dynamic blood single-cell immune responses in patients with COVID-19 (2021 · Signal Transduction and Targeted Therapy · 被引 127)
• Emergence and global spread of a dominant multidrug-resistant clade within Acinetobacter baumannii (2025 · Nature Communications · 被引 65)
• Single-cell transcriptome reveals diversity of Müller cells with different metabolic-mitochondrial signatures in normal and degenerated macula (2022 · Frontiers in Neuroscience · 被引 22)
• Lobaplatin-based neoadjuvant chemotherapy for triple-negative breast cancer: a 5-year follow-up of a randomized, open-label, phase II trial (2022 · Therapeutic Advances in Medical Oncology · 被引 18)
• KleTy: integrated typing scheme for core genome and plasmids reveals repeated emergence of multi-drug resistant epidemic lineages in Klebsiella worldwide (2024 · Genome Medicine · 被引 13)
• Mesenchymal stem cells transplantation attenuates hyperuricemic nephropathy in rats (2021 · International Immunopharmacology · 被引 13)